ARTICLE | Company News
BioMarin endocrine/metabolic news
October 13, 2014 7:00 AM UTC
BioMarin said an undisclosed company submitted an ANDA to FDA for a generic version of the biotech's Kuvan sapropterin dihydrochloride to treat phenylketonuria. BioMarin said it has eight patents cov...